Labeling of injectable medicines administered in anesthesia;Etiquetado de los medicamentos inyectables que se administran en anestesia

Revista Espanola de Anestesiologia y Reanimacion

Volumn 58, Issue 6, 2011, Pages 375-383

  Gomez Arnau J I ^a,b,c   Otero, M J ^a,b,c   Bartolome A ^a,b,c   Errando, C L ^a,b,c   Arnal, D ^a,b,c   Moreno, A M ^a,b,c   Puebla, G ^a,b,c   Marzal, J M ^a,b,c   Santa Ursula J A ^a,b,c   Gonzalez R ^a,b,c   Perez M ^a,b,c   Garcia del Valle S ^a,b,c   Gonzalez A ^a,b,c   Dominguez Gil A ^a,b,c  

^a Recomendaciones de la Sociedad Española de Anestesiología   (Spain)

^b Sistema Español de Notificación en Seguridad en Anestesia y Reanimación SENSAR   (Spain)

^c Instituto para el Uso Seguro de los Medicamentos ISMP España   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHESIA; ARTICLE; DRUG LABELING; HUMAN; INJECTION; MEDICATION ERROR; PRACTICE GUIDELINE; STANDARD; SYRINGE;

ANESTHESIA; DRUG LABELING; HUMANS; INJECTIONS; MEDICATION ERRORS; SYRINGES;

EID: 80052233736     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0034-9356(11)70087-1     Document Type: Article

References (56)

1. Committee on Identifying and Preventing Medication Errors. Aspden, P., Wolcott, J.A., Lyle Bootman, J., Cronenwett, L.R., (eds.) Preventing medication errors. Institute of Medicine, 2007, National Academy Press, Washington (DC).
2. Expert Group on Safe Medication Practices. Creation of a better medication safety culture in Europe: Building up safe medication practices. Marzo 2007. Disponible en: http://www.coe.int/t/e/social_cohesion/socsp/Medication%20safety%20culture%20report%20E.pdf.
3. Otero López, M.J., Errores de medicación y gestión de riesgos. Rev Esp Salud Pública 77 (2003), 527–540.
4. Taxis, K., Barber, N., Ethnographic study of incidence and severity of intravenous drug errors. Br Med J 326 (2003), 684–688.
5. Taxis, K., Barber, N., Causes of intravenous medication errors: an ethnographic study. Qual Saf Health Care 12 (2003), 343–348.
6. Cousins, D.H., Sabatier, B., Begue, D., Schitt, C., Hoppe-Tichy, T., Medication errors in intravenous drug preparation and administration: a multicentre audit in the UK, Germany and France. Qual Saf Health Care 14 (2005), 190–195.
7. Valentin, A., Capuzzo, M., Guidet, B., Moreno, R., Metnitz, B., Bauer, P., et al. Errors in administration of parenteral drugs in intensive care units: multinational prospective study. BMJ, 338, 2009, b814.
8. The Joint Commission. 2006 National Patient Safety Goals. Disponible en: http://www.jointcommission.org/PatientSafety/NationalPatientSafetyGoals/.
9. Institute for Safe Medication Practices. Errors with injectable medications: Unlabeled syringes are surprisingly common!. ISMP Medication Safety Alert! 12:23 (2007), 1–2 Disponible en: http://www.ismp.org/newsletters/acutecare/articles/20071115.asp.
10. Promoting safer use of injectable medicines. National Patient Safety Agency, 2007. Disponible en: http://www.nrls.npsa.nhs.uk/resources/?entryid45=59812.
11. Cuestionario de autoevaluación de la seguridad del sistema de utilización de los medicamentos en los hospitales. Adaptación del ISMP Medication Safety Self-Assessment for Hospitals, por el Instituto para el Uso Seguro de los Medicamentos (ISMP-España), 2007, Ministerio de Sanidad y Consumo, Madrid Disponible en: http://www.msc.es/organizacion/sns/planCalidadSNS/pdf/excelencia/cuestionario_seguridad_sistema_medicamentos_hospitales.pdf.
12. Australian Commission on Safety and Quality in Healthcare. National Recommendations for user-applied labelling of injectable medicines, fluids and lines. August 2010. Disponible en: http://www.health.gov.au/internet/safety/publishing.nsf/Content/PriorityProgram-06_UaLIMFL.
13. Joint Commission. Tubing misconnections—a persistent and potentially deadly occurrence. Sentinel Event Alert. 2006 Apr 3. Disponible en: http://www.jointcommission.org/sentinel_event_alert_issue_36_tubing _misconnections%E2%80%94a_persistent_and_potentially_deadly_o ccurrence/.
14. World Health Organization. World Alliance for Patient Safety. Avoiding catheter and tubing mis-connections. Patient Safety Solutions. Solution 7. May 2007. Disponible en: http://www.ccforpatientsafety.org/common/pdfs/fpdf/presskit/PS-Solution7.pdf.
15. Pennsylvania Patient Safety Advisory. Tubing misconnections: making the connection to patient safety. Pa Patient Saf Advis 7 (2010), 41–45.
16. Webster, C.S., Merry, A.F., Larsson, L., MacGrath, K.A., Weller, J., The frequency and nature od drug administration error during anaesthesia. Anaesth Intensive Care 29 (2001), 494–500.
17. US Pharmacopeia. Medication errors in the perioperative environment. USP Patient safety CAPSLink, 2003 March, 1–5.
18. Abeysekera, A., Bergman, I.J., Kluger, M.T., Short, T.G., Drug error in the anesthetic practice: a review of 896 reports from the Australian Incident Monitoring Study database. Anaesthesia 60 (2005), 220–227.
19. Gordon, P.C., Wrong drug administration errors amongst anesthetists in a South African teaching hospital. South Afr J Anaesth Analg 5 (2004), 7–8.
20. Bartolomé Ruibal, A., Gómez-Arnau Díaz-Cañabate, J.I., Santa-Úrsula Tolosa, J.A., Marzal Baró, J.M., González Arévalo, A., García del Valle Manzano, S., et al. Utilización de un sistema de comunicación y análisis de incidentes críticos en un servicio de anestesia. Rev Esp Anestesiol Reanim 53 (2006), 471–478.
21. Errando, C.L., Blasco, P., Errores relacionados con la administración de medicamentos en anestesiología, reanimación-cuidados críticos y urgencias. Factores para mejorar la seguridad y calidad. Rev Esp Anestesiol Reanim 53 (2006), 397–399.
22. Jensen, L.S., Merry, A.F., Webster, C.S., Weller, J., Larsson, L., Evidence-based strategies for preventing drug administration errors during anaesthesia. Anaesthesia 59 (2004), 493–504.
23. Merali, R., Orser, B.A., Leeksma, A., Lingard, S., Belo, S., Hyland, S., Medication safety in the operating room: teaming up to improve patient safety. Healthcare Quaterly 11 (2008), 54–57.
24. Glavin, R.J., Drugs errors: consequences, mechanisms, and avoidance. Br J Anaesth 105 (2010), 76–82.
25. Eichhorn, J.H., APSF hosts medication safety conference. Consensus group defines challenges and opportunities for improved practice. APSF Newsletter 25 (2010), 1–8.
26. Mellin-Olsen, J., Staender, S., Whitaker, D.K., Smith, A.F., The Helsinki Declaration on patient safety in Anaesthesiology. Eur J Anaesthz 27 (2010), 592–597.
27. Mellin-Olsen, J., Pelosi, P., Van Aken, H., Declaración de Helsinki sobre la seguridad de los pacientes en Anestesiología (Versión extractada en español de 26. Rev Esp Anestesiol Reanim 57 (2010), 594–595 bis.
28. Working Party on Safety and Quality of Care. Guidelines for safety and quality in anaesthesia practice in the European Union. Eur J Anaesth 24 (2007), 479–482.
29. American Society of Anesthesiologists. Statement on the labeling of pharmaceuticals for use in Anesthesiology. October 2009. Disponible en: http://www.asahq.org/For-Healthcare-Professionals/Standards-Guidelines-and-Statements.aspx.
30. American Society for Testing and Materials. ASTM D4774–06 Standard specification for user applied drug labels in Anesthesiology. Disponible en: http://www.astm.org/Standards/D4774.htm.
31. International Organization for Standardization. User-applied labels for syringes containing drugs used during anesthesia. Colours, design and performance. ISO 26825:2008. Disponible en: http://www.iso.org/iso/iso_catalogue/catalogue_tc/catalogue_detail.htm?csnumber=43811.
32. Canadian Standards Association. Standard for user-applied drug labels in anesthesia and critical care, CAN/CSA- Z264.3; 1998. Disponible en: http://www.shopcsa.ca/onlinestore/electronic_catalogue/English_Catalogue.pdf.
33. Canadian Anaesthesiologist s Society. Guidelines to the practice of Anesthesia. Can J Anesth 57 (2010), 58–87 Disponible en: http://www.cas.ca/English/Page/Files/97_Standards_2010EN.pdf.
34. ser- applied labels for use on syringes containing drugs used during anaesthesia, AS/NZS 4375: 1996, Joint Australian/New Zealand standard, prepared by joint technical committee HT/7. U. Standards Australia and Standards New Zealand, 1996, 1–5 Disponible en: http://www.hunter.health.nsw.gov.on/ducs/ CGU_02_08.pdf.
35. Australian and New Zealand College of Anaesthetists. Guidelines for the safe administration of injectable drugs in Anaesthesia, PS51 (2009). Disponible en: http://www.anzca.edu.au/resources/professional-documents/pdf/PS51.pdf.
36. Royal College of Anaesthetists, Association of Anaesthetists of Great Britain and Ireland, Faculty of Accident and Emergency Medicine, Intensive Care Society. Syringe labelling in critical care areas. RcoA Bulletin, 19, May 2003, 953.
37. Royal College of Anaesthetists, Association of Anaesthetists of Great Britain and Ireland, Faculty of Accident and Emergency Medicine, Intensive Care Society. Syringe labelling in critical care areas. June 2004 update. Disponible en: http://www.aagbi.org/publications/guidelines/docs/syringelabels(june)04.pdf.
38. Société Française d Anesthésie et de Réanimation. Prévention des erreurs médicamenteuses en anesthésie. Recommandations de la Sfar. Novembre 2006. Disponible en: http://www.sfar.org/_docs/articles/preverreurmedic_recos.pdf.
39. SIAARTI Study Group on Safety in Anesthesia and Critical Care. Syringe labelling in anesthesia and intensive care. Disponible en: http://www.siaarti.it/documenti/pdf_doc/file_4.pdf.
40. Birks, R.J.S., Simpson, P.J., Syringe labelling- an international standard. Anaesthesia 58 (2003), 515–519.
41. Shannon, J., Riain, O.S., Introduction of “international syringe labelling” in the Republic of Ireland. Ir J Med Sci 178 (2009), 291–296.
42. Wheeler, S.J., Wheeler, D.W., Medication errors in anaesthesia and critical care. Anaesthesia 60 (2005), 257–273.
43. Institute for Safe Medication Practices. Color-coded syringes for anesthesia drugs: use with care. ISMP Medication Safety Alert! 13 (2008), 1–2.
44. Report 5 of the Council on Scientific Affairs (A-04) full text. The role of color coding in medication error reduction, 2004, American Medical Association, Chicago (IL) Disponible en: http://www.amaassn.org/ama/no-index/about-ama/13662.shtml.
45. Filiatrault, P., Hyland, S., Does colour-coded labeling reduce the risk of medication errors?. CJHP 62 (2009), 154–156.
46. ISMP-Canada. Operating room medication safety checklist. Version 2, 2009, ISMP-Canada, Toronto.
47. National Patient Safery Agency. Neuraxial Update. Issue 01 August 2010. Disponible en: http://www.patientsafetyfirst.nhs.uk/ashx/ Asset.ashx?path=/Medicationsafety/NPSA-Neuraxial%20Update%20Newsletter-Aug%202010.pdf.
48. National Patient Safety Agency. Supporting information for rapid response report NPSA/2008/RRR06. Problems with infusions and sampling from arterial lines, 28 July 2008. Disponible en: www.nrls.npsa.nhs.uk/resources/?entryid45=59891.
49. National Patient Safety Agency. Patient Safety Alert 19. Promoting safer measurement and administration of liquid medicines via oral and other enteral routes. 28 March 2007. Disponible en: www.nrls.npsa.nhs.uk/resources/?entryid45=59808.
50. Instituto para el Uso Seguro de los Medicamentos. Lista de medicamentos de alto riesgo. ISMP-España. Enero 2008. Disponible en: http://www.ismp-espana.org/ficheros/Medicamentos%20alto%20riesgo.pdf.
51. Wheeler, D.W., Remoundos, D.D., Whittlestone, K.D., Palmer, M.I., Wheeler, S.J., Ringrose, T.R., et al. Doctor s confusion over ratios and percentages in drug solutions: the case for standard labelling. J R Soc Med, 2004, 380–383.
52. Wheeler, D.W., Carter, J.J., Murray, L.J., Degnan, B.A., Dunling, C.P., Salvador, R., et al. The effect of drug concentration expression on epinephrine dosing errors. Ann Intern Med 148 (2008), 11–14.
53. Institute for Safe Medication Practices. FDA and ISMP lists of look-alike drug name sets with recommended tall man letters. Disponible en: http://www.ismp.org/tools/tallmanletters.pdf.
54. Hellier, E., Edworthy, J., Derbyshire, N., Costello, A., Considering the impact of medicine label design characteristics on patient safety. Ergonomics 49 (2006), 617–630.
55. Filik, R., Purdy, K., Gale, A., Gerret, D., Labeling of medicines and patient safety: Evaluating methods of reducing drug name confusion. Human Factors 48 (2006), 39–47.
56. Otero López, M.J., Martín Muñoz, R., Domínguez-Gil Hurlé, A., Abreviaturas, símbolos y expresiones de dosis asociados a errores de medicación. Farm Hosp 28 (2004), 141–144.